Synthesis by Jeffrey Bland
“ We need to listen to the patients' story and develop a response to it. The approach to complex syndromes may be much more profound than just trying to point a round peg into a square hole and get a singular diagnosis. ”
Jeffrey S. Bland, PhD

Exclusively Available from
Synthesis by Jeffrey Bland, PhD

Date Topics 
1/1/2011 Mark Tarnopolsky
PhD McMaster University
McMaster University
Neuromuscular and neurometabolic diseases; mitochondrial disease and dysfunction; muscle disease, including sarcopenia; and aging and oxidative stress.
2/1/2011 David Sinclair
Harvard Medical School
Calorie restriction, Cellular aging, sirtuins, xenohormesis, molecular gerontology, mTOR, rapamycin
3/1/2011 Steven Gundry
International Heart & Lung Institute
Diet, lifestyle medicine, heart disease, coronary artery disease, cardiothoracic surgery, weight loss
4/1/2011 Garry Egger
Southern Cross University
lifestyle medicine, inflammation, chronic disease, economic growth, global health trends
5/1/2011 Mark Hyman
Chairman, Institute for Functional Medicine
Institute for Functional Medicine, IFM, Functional Medicine Update, FMU, Symposium, Anniversary, Functional Medicine
6/1/2011 Nathan Bryan
PhD University of Texas
University of Texas
Nitric oxide, NO, nitrites, nitrates, cardiovascular disease, sildenafil, cGMP,cyclic GMP, anion, l-arginine
7/1/2011 Edwin Lephart
PhD Brigham Young University
Brigham Young University
Soy, equol, estrogen, phytoestrogen, vitamin A, phytochemicals, glucosinolates
8/1/2011 Garth L. Nicolson
Institute of Molecular Medicine
Cell membrane; Fluid Mosaic model; mitochondrial function; lipids; fatty acids; chronic fatigue syndrome; bioenergetics
9/1/2011 Gerard Mullin & Kathie Swift
Authors, The Inside Tract
Integrative gastoenterology, digestion, GI tract, Barrett's esophagus, Crohn's disease, irritable bowel syndrome, IBS, colitis, nutrition, diet
10/1/2011 Clinician Roundtable
Lifestyle Medicine, patient education, communication, Kristi Hughes, David Jones, Graham Reedy, Jay Lombard, James Weiss, Ken Browning, Mark McIntosh
11/1/2011 Clinician Roundtable Part II
Lifestyle medicine, global healthcare economy, chronic disease, small inhibitory RNAs (siRNAs), microRNAs (miRNAs)
12/1/2011 Susan Brienza
Dietary supplements, medical foods, DSHEA, guidelines, FDA, FTC, law, EPA, DHA